Department of Medicine 3 – Rheumatology and Immunology

Projekt A2: Intestinaler Epithelzelltod als Modulator der intestinalen Dysbiose, systemische Autoimmunität und das Auftreten von Arthritis (FOR 2886 PANDORA A2) FOR 2886: PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis July 1, 2019 - June 30, 2024 Projekt A2: Intestinaler Epithelzelltod als Modulator der intestinalen Dysbiose, systemische Autoimmunität und das Auftreten von Arthritis FOR 2886: PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis July 1, 2019 - June 30, 2024 J090: Regulatory functions of eosinophils during pathological bone remodelling Jan. 1, 2022 - June 30, 2024 Mechanisms of chronic fibroblast dysfunction and risk assessment in fibrosing disorders March 1, 2023 - Feb. 29, 2024 A092: Targeting draining lymph node scaffold cells to induce immune tolerance Sept. 1, 2020 - Feb. 29, 2024 A077: HIF pathway activation in B cells regulates postmenopausal bone loss Dec. 16, 2020 - Dec. 15, 2023 P116: The role of Butyrophilin 2a2 (Btn2a2) in T cell maturation Oct. 1, 2022 - Sept. 30, 2023 P089: Effect of Yoga-Intervention on Spine Flexibility and Mobility in Patients with axial Spondylarthritis Oct. 1, 2022 - Sept. 30, 2023 P106: Diet-induced function of Aryl hydrocarbon Receptor (AhR) during establishment of the humoral immune response Sept. 1, 2022 - Aug. 31, 2023 P104: Combined inhibition of Hedgehog- and AP1-signaling as novel therapeutic strategy in fibrotic disease Aug. 1, 2022 - July 31, 2023